Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Pill organizers and cutters can help with taking medication regularly but may affect the medication's effectiveness and safety.

Nutrient antioxidants helped reduce prednisolone dosage and improved hair growth in alopecia areata patients.

The data suggests that dosing differences can help manage spasticity in patients with upper motor neuron dysfunction.

Combination therapy is more effective for prostate volumes over 60 ml.

Low-dose Buserelin effectively reduces hirsutism with minimal side effects.

A well-equipped resident's bag enhances clinical skills, preparation, confidence, and learning for junior doctors.

Early diagnosis and biotin treatment are crucial for infants with biotinidase deficiency to prevent severe complications.

Confirming low-dose endocrine toxicities is difficult and requires more research.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

Switching to a twice-weekly betamethasone treatment led to full hair regrowth in alopecia areata without side effects.

Bezafibrate treatment improved skin and spleen health in aging mice but didn't extend lifespan.

Calancardin B may help reduce inflammation in immune cells.

Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.

The UD-PrOZA program successfully diagnosed 18% of adult patients with rare diseases, often using genetic testing.

Many patients in the rheumatology clinic adjusted or stopped their medications due to side effects.

Prurigo nodularis is hard to diagnose and treat, but new biologics offer hope for better management.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

RF-mesotherapy with bicalutamide may be a promising new treatment for hair loss.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Doctors need to be better prepared to assess and treat obesity in patients.

Microneedles offer a painless, precise, and versatile method for drug delivery and disease treatment.

The COVID-19 pandemic has led to more severe cases of Leprosy due to delayed medical care.

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

Recognizing oral symptoms can help diagnose and treat blood and nutritional diseases early.